Developed in collaboration with Deloitte Consulting LLP, the US Biopharmaceutical Finished Goods Supply Chain Response to COVID-19 report provides insights into the role that the supply chain played in ensuring delivery and availability of medicines during the first 90 days of the COVID-19 pandemic. In this webinar, you will receive an in-depth look at key findings from the report, including:
The report will be published and made available as a complimentary download through the HDA website later this Fall.
Rob Jacoby, Principal, Deloitte Consulting LLP
Matt Heim, Senior Manager, Deloitte Consulting LLP
Cinthya Fernandez Preda, Manager, Deloitte Consulting LLP
Perry Fri, Executive Vice President, Industry Relations, Membership & Education, HDA; COO, HDA Research Foundation (Moderator)